¡Ya estamos en ! Descubre más
61.47 USD
+1.23
2.04%
Al cierre Actualizado 16 oct, 4:00 p.m. EDT
Antes de la apertura del mercado
Después del cierre del mercado
61.47
0.00
0%
1 día
2.04%
5 días
5.46%
1 mes
6.7%
3 meses
4.13%
6 meses
-11.2%
En lo que va del año
-28.91%
1 año
-26.78%
5 años
-27.65%
10 años
13.88%
 

Acerca de: Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.

Empleados: 37,200

Noticias

Positivo
Neutral
Negativo
Sentimiento 3 meses
Positivo 60%
Neutral 30%
Negativo 10%
Negativo
Seeking Alpha
hace 22 días
Maximus: A Discount To Peers, Even If The Recent Contract Change Is Permanent
Maximus cut fiscal 2026 adjusted EPS guidance to $7.90-$8.20 after the VA paused performance incentive payments in its medical exam program from July 1 through Dec. 31, 2026. At $55.18, MMS trades at 6.9x the $8.05 guidance average. Without the incentives, our math puts annual adjusted EPS near $7, or 7.9x, still below every peer. MMS trades at 8.2x trailing earnings against 11.5x for Leidos and 12x for Booz Allen, with a 15% trailing free cash flow yield and the lowest leverage in its peer group.
Maximus: A Discount To Peers, Even If The Recent Contract Change Is Permanent
Positivo
Zacks Investment Research
hace 2 meses
Can Maximus Weather the VA Contract Hit and Rebuild Earnings Momentum?
Maximus faces an earnings reset as paused VA incentives cut profit and cash-flow guidance, testing whether service and tech gains can rebuild momentum.
Can Maximus Weather the VA Contract Hit and Rebuild Earnings Momentum?
Neutral
Zacks Investment Research
hace 2 meses
Is Maximus Stock Worth Buying as Low Valuation Meets Contract Risk?
Maximus trades at a deep earnings discount, but federal procurement delays and weak award conversion cloud the timing of a recovery.
Is Maximus Stock Worth Buying as Low Valuation Meets Contract Risk?
Positivo
MarketBeat
hace 2 meses
Maximus Q3 Earnings Call Highlights
Maximus NYSE: MMS reported fiscal 2026 third-quarter revenue of $1.28 billion, with adjusted EBITDA margin of 15.0% and adjusted diluted earnings per share of $2.22. Revenue was in line with the company's expectations, while adjusted EBITDA margin improved from 14.7% a year earlier and adjusted EPS rose from $2.16.
Maximus Q3 Earnings Call Highlights
Positivo
Zacks Investment Research
hace 2 meses
Maximus Q3 Earnings Beat Estimates, Increase Year Over Year
MMS beats fiscal Q3 earnings estimates but misses on revenues, while higher margins contrast with softer sales and reduced 2026 profit guidance.
Maximus Q3 Earnings Beat Estimates, Increase Year Over Year
Neutral
Seeking Alpha
hace 2 meses
Maximus, Inc. (MMS) Q3 2026 Earnings Call Transcript
Maximus, Inc. (MMS) Q3 2026 Earnings Call Transcript
Maximus, Inc. (MMS) Q3 2026 Earnings Call Transcript
Neutral
Zacks Investment Research
hace 2 meses
Here's What Key Metrics Tell Us About Maximus (MMS) Q3 Earnings
While the top- and bottom-line numbers for Maximus (MMS) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Here's What Key Metrics Tell Us About Maximus (MMS) Q3 Earnings
Positivo
Zacks Investment Research
hace 2 meses
Maximus (MMS) Q3 Earnings Beat Estimates
Maximus (MMS) came out with quarterly earnings of $2.22 per share, beating the Zacks Consensus Estimate of $2.2 per share. This compares to earnings of $2.16 per share a year ago.
Maximus (MMS) Q3 Earnings Beat Estimates
Positivo
Zacks Investment Research
hace 2 meses
Maximus (MMS) Could Be a Great Choice
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Maximus (MMS) have what it takes?
Maximus (MMS) Could Be a Great Choice
Positivo
Zacks Investment Research
hace 2 meses
Here's Why Maximus (MMS) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Maximus (MMS) is a Strong Growth Stock
Gráficos de precios implementados con Lightweight Charts™